XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.37

-8.4%

Jan 16 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (9969)	5/14/1999 3:26:00 PM
From: PrometheusTex	Read Replies (3) of 17367

Good afternoon, The recent movement in volume and price has me back and paying attention to XOMA, and I finally decided to acquire better season tickets. The seats over at Yahoo were getting rowdy. My take from the scientists that I know who follow XOMA is that they are more concerned about the FDA than the drug itself. And they do point to E5 as an example of FDA difficulties >> drug difficulties. However, in this area I am quick to point out that I was not around for that fun. About the pink thing, it is my understanding that at least some significant part of the present range of applications/patents comes directly from the observations by the docs in phase II. (It is difficult for in-house biotech scientists to make the most important observations in a trial.) This change was so obvious, the Phase II docs find it hard to believe anyone could miss it. So listen for leaks now that the trial is finished. I personally will be surprised if there are none. Hope you don't mind me crashing the party. I will, as George once suggested to me over at Yahoo, try to stick to the science. I did vote no, BTW. ProTex

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next